Patents by Inventor John Kehoe
John Kehoe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11920538Abstract: An anti-polish ring for an internal combustion engine is provided. The anti-polish ring includes an axially extending ring portion that is configured to scrape a top portion of a piston in a cylinder liner. The anti-polish ring is configured to accommodate passage of an intake or exhaust valve thereby. The anti-polish ring may include an alignment feature so that the anti-polish ring is inserted in a predetermined orientation in the cylinder. The anti-polish ring may include a heat shield and/or a seating member.Type: GrantFiled: November 3, 2022Date of Patent: March 5, 2024Assignee: Cummins Inc.Inventors: Owen Summerfield, Craig Daniel Fox, Robert Harries, Jamie Kehoe, Kent H. Clark, John M Antonevich, Reid M. Irish, Scott A. Ragon, Stephen G. Townsend, Peter Thomas Quanz
-
Publication number: 20220348647Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.Type: ApplicationFiled: June 29, 2022Publication date: November 3, 2022Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
-
Patent number: 11414484Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.Type: GrantFiled: October 1, 2020Date of Patent: August 16, 2022Assignee: Janssen Biotech, Inc.Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
-
Publication number: 20220064938Abstract: A construction material structure, comprising a plurality of inner support columns, the support columns being fixtured at the top end portion and/or the bottom end portion in a generally parallel, spaced apart arrangement, a polymeric film stretched across a first side and an opposite second side of the support columns, a quick cure polymeric fibrous material formed on the outer surface of the stretched polymeric film, and a polymeric foam disposed between the support columns and the stretched polymeric film.Type: ApplicationFiled: November 9, 2021Publication date: March 3, 2022Applicant: VBBT CorpInventors: Yuk-Kwan Brian Yuen, Venesia Hurtubise, William John Kehoe, Thomas J. Kennedy, III
-
Patent number: 11168485Abstract: A low cost and disaster relief housing solution includes the combination of preconstructed in-service or out-of-service shipping containers that are integrated with renewable and sustainable materials to complete the buildout of the shipping containers. The embodiment also includes folding solutions that allows for a superior logistic solution for shipping and site integration.Type: GrantFiled: September 14, 2019Date of Patent: November 9, 2021Assignee: VBBT Corp.Inventors: Yuk-Kwan Brian Yuen, Venesia Hurtubise, William John Kehoe, Thomas J Kennedy, III
-
Publication number: 20210017267Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.Type: ApplicationFiled: October 1, 2020Publication date: January 21, 2021Inventors: Ken BOAKYE, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
-
Patent number: 10829549Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.Type: GrantFiled: December 8, 2017Date of Patent: November 10, 2020Assignee: Jannsen Biotech, Inc.Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
-
Patent number: 10730950Abstract: Provided herein are antibodies that specifically bind to GITR. Also described are related polynucleotides capable of encoding the provided GITR-specific antibodies or antigen-binding fragments, cells expressing the provided antibodies or antigen-binding fragments, as well as associated vectors and detectably labeled antibodies or antigen-binding fragments. In addition, methods of using the provided antibodies are described. For example, the provided antibodies may be used to enhance an immune response in a subject against cancer.Type: GrantFiled: March 8, 2017Date of Patent: August 4, 2020Assignee: Janssen Biotech, Inc.Inventors: Cam Holland, John Kehoe, Linda Snyder, Alejandro Sepulveda, Daniel Villarreal
-
Publication number: 20200087939Abstract: A low cost and disaster relief housing solution includes the combination of preconstructed in-service or out-of-service shipping containers that are integrated with renewable and sustainable materials to complete the buildout of the shipping containers. The embodiment also includes folding solutions that allows for a superior logistic solution for shipping and site integration.Type: ApplicationFiled: September 14, 2019Publication date: March 19, 2020Applicant: VBBT CorpInventors: Yuk-Kwan Brian Yuen, Venesia Hurtubise, William John Kehoe, Thomas J Kennedy, III
-
Publication number: 20180171007Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.Type: ApplicationFiled: December 8, 2017Publication date: June 21, 2018Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
-
Patent number: 9944697Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.Type: GrantFiled: November 6, 2014Date of Patent: April 17, 2018Assignee: JANSSON BIOTECH, INC.Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
-
Publication number: 20170260282Abstract: Provided herein are antibodies that specifically bind to GITR. Also described are related polynucleotides capable of encoding the provided GITR-specific antibodies or antigen-binding fragments, cells expressing the provided antibodies or antigen-binding fragments, as well as associated vectors and detectably labeled antibodies or antigen-binding fragments. In addition, methods of using the provided antibodies are described. For example, the provided antibodies may be used to enhance an immune response in a subject against cancer.Type: ApplicationFiled: March 8, 2017Publication date: September 14, 2017Inventors: Cam Holland, John Kehoe, Linda Snyder, Alejandro Sepulveda, Daniel Villareal
-
Patent number: 9248194Abstract: We have disclosed affinity peptides toward infliximab. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for infliximab.Type: GrantFiled: July 23, 2014Date of Patent: February 2, 2016Assignee: Janssen Biotech, Inc.Inventors: Daphne Ann Salick Ryan, John Kehoe, John Wheeler, Chunlin Yang, Abla Creasy
-
Publication number: 20150125458Abstract: The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.Type: ApplicationFiled: November 6, 2014Publication date: May 7, 2015Inventors: Ken Boakye, Alfred Del Vecchio, John Kehoe, Eilyn Lacy, Lynne Murray, Mary Ryan, Sandra Santulli-Marotto, John Wheeler, Brian Whitaker, Alexey Teplyakov
-
Patent number: 8906649Abstract: The present invention relates to antibodies against human collagen II, polypeptides and polynucleotides encoding human collagen II antibodies or fragments thereof, and methods of making and using the foregoing.Type: GrantFiled: February 6, 2013Date of Patent: December 9, 2014Assignee: Janssen Biotech, Inc.Inventors: John Kehoe, Tatiana Ort, Kristen Picha, Mary Ryan, John Wheeler, Jennifer Lee Gardiner
-
Publication number: 20140328837Abstract: We have disclosed affinity peptides toward infliximab. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for infliximab.Type: ApplicationFiled: July 23, 2014Publication date: November 6, 2014Inventors: Daphne Ann Salick Ryan, John Kehoe, John Wheeler, Chunlin Yang, Abla Creasy
-
Patent number: 8822423Abstract: We have disclosed affinity peptides toward infliximab. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for infliximab.Type: GrantFiled: May 17, 2012Date of Patent: September 2, 2014Assignee: Janssen Biotech, Inc.Inventors: Daphne Ann Salick Ryan, John Kehoe, John Wheeler, Chunlin Yang, Abla Creasey
-
Publication number: 20140220634Abstract: The present invention relates to antibodies against human collagen II, polypeptides and polynucleotides encoding human collagen II antibodies or fragments thereof, and methods of making and using the foregoing.Type: ApplicationFiled: February 6, 2013Publication date: August 7, 2014Applicant: Janssen Biotech, Inc.Inventors: John Kehoe, Tatiana Ort, Kristen Picha, Mary Ryan, John Wheeler, Jennifer Lee Gardiner
-
Patent number: 8629106Abstract: We have disclosed affinity peptides toward BMP-2. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for BMP-2.Type: GrantFiled: March 10, 2011Date of Patent: January 14, 2014Assignee: Janssen Biotech, Inc.Inventors: John Kehoe, Daphne A. Salick, Carrie H. Fang, Chunlin Yang, Abla Creasey
-
Publication number: 20130309222Abstract: We have disclosed affinity peptides toward infliximab. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for infliximab.Type: ApplicationFiled: May 17, 2012Publication date: November 21, 2013Applicant: Advanced Technologies and Regenerative Medicine, LLCInventors: Daphne Ann Salick Ryan, John Kehoe, John Wheeler, Chunlin Yang, Abla Creasey